Advertisement

Topics

VIDEO: Improved physical function for patients with RA when switched from adalimumab to sarilumab

02:00 EST 8 Nov 2017 | Healio

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Gerd R. Burmester, MD, spoke about the efficacy and safety of switching from adalimumab to sarilumab in an open-label extension of the MONARCH trial.
Burmester said results showed that patients with rheumatoid arthritis had improved physical function when switched from adalimumab 40 mg monotherapy to sarilumab 200 mg every 2 weeks. Additionally, the researchers found the safety profile for this open-label extension trial was consistent with the safety profile found in the MONARCH trial.

Original Article: VIDEO: Improved physical function for patients with RA when switched from adalimumab to sarilumab

NEXT ARTICLE

More From BioPortfolio on "VIDEO: Improved physical function for patients with RA when switched from adalimumab to sarilumab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...